Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma.

J Pharm Anal · 2023 · PMC10257150 · PMID 37305788

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

By contrast, a decreasing trend was found for anti-apoptotic proteins such as Bcl-2.

also in 47,180 other papers

an increasing trendno p-value reported

Indeed, the abundance of these pro-apoptotic proteins showed an increasing trend as the Rk3 dosage increased ( Figs. 5 C and D).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.